DSM and ROQUETTE to commercialize bio-based succinic acid as of end 2009
For the first time succinic acid - a chemical building block used in the manufacture of polymers, resins, food and pharmaceuticals among other products - will be produced using biological means. DSM and ROQUETTE have developed a method to produce succinic acid from starch using an innovative enzyme-based fermentation technology rather than the traditional ingredients, crude oil and natural gas. The Lestrem demonstration plant will enable this manufacturing process to be refined further before it is scaled-up to full commercial industrial production in 2011/2012. This new white biotechnology-based route could result in up to 40% reduction in energy requirements compared to the traditional method, and have a positive impact on reducing CO2 emissions, as carbon dioxide is actually used in the production process.
In addition to the sustainability benefits, the successful production of bio-succinic acid at the industrial level will help provide the knowledge, economies of scale and open up new markets and applications for bio-based products in other fields including pharmaceuticals, fuel, chemicals, food and feed and materials.
Topics
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.